CW November 2003
Volume 12Issue Number 11 November 2003 ISSN 10593802 A New Anti-cancer Agent for Non-Small Cell Lung CancerGefinitib (Iressa), a new anti-cancer agent that blocks the signals transmitted by growth-promoting hormones that tell cancer cells to proliferate is approved by the Federal Drug Administration to treat advanced non-small lung cancer patients.
Go to Previous Page Go to Next Page Source & Additional Reading M. Kris et al., Journal of the American Medical Association, October 22, 2003. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW November 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
